Koppert and Amoéba Partner on Innovative Biofungicide

Amoeba SA (FR:ALMIB) has released an update.

Koppert, a leader in biological crop protection, and Amoéba, a greentech company, have signed a Memorandum of Understanding to jointly launch a groundbreaking biofungicide named AXPERA. This partnership aims to enhance sustainable agriculture by utilizing Amoéba’s innovative amoeba-based solution to combat fungal diseases. The collaboration will focus on distribution, production, and regulatory approvals, with AXPERA expected to hit the European market by the end of 2025.

For further insights into FR:ALMIB stock, check out TipRanks’ Stock Analysis page.